Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 02-04-2026
NAV ₹13.21(R) -1.03% ₹13.72(D) -1.03%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 4.9% -% -% -% -%
Direct 6.72% -% -% -% -%
Nifty Pharma TRI 4.84% 22.69% 12.82% 13.82% 7.84%
SIP (XIRR) Regular -4.01% -% -% -% -%
Direct -2.33% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -

NAV Date: 02-04-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 13.21
-0.1400
-1.0300%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 13.72
-0.1400
-1.0300%

Review Date: 02-04-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -4.74 -5.00
-4.95
-6.68 | -2.52 7 | 15 Good
3M Return % -4.76 -4.10
-5.33
-8.17 | -3.12 7 | 15 Good
6M Return % -3.39 0.48
-4.43
-7.72 | -0.88 6 | 15 Good
1Y Return % 4.90 4.84
1.35
-3.58 | 6.49 2 | 14 Very Good
1Y SIP Return % -4.01
-6.78
-11.96 | -0.84 4 | 14 Very Good
Return data last Updated On : April 2, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -4.60 -5.00 -4.83 -6.57 | -2.39 6 | 15 Good
3M Return % -4.37 -4.10 -5.00 -7.87 | -2.77 7 | 15 Good
6M Return % -2.57 0.48 -3.76 -7.11 | -0.31 6 | 15 Good
1Y Return % 6.72 4.84 2.76 -2.33 | 7.76 2 | 14 Very Good
1Y SIP Return % -2.33 -5.46 -10.63 | 0.34 3 | 14 Very Good
Return data last Updated On : April 2, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
02-04-2026 13.212 13.717
01-04-2026 13.35 13.86
30-03-2026 13.39 13.9
27-03-2026 13.573 14.089
25-03-2026 13.708 14.227
24-03-2026 13.495 14.006
23-03-2026 13.307 13.809
20-03-2026 13.612 14.125
19-03-2026 13.387 13.89
18-03-2026 13.685 14.198
17-03-2026 13.567 14.075
16-03-2026 13.421 13.923
13-03-2026 13.529 14.034
12-03-2026 13.828 14.343
11-03-2026 13.897 14.414
10-03-2026 13.88 14.396
09-03-2026 13.733 14.243
06-03-2026 13.818 14.329
05-03-2026 13.848 14.359
04-03-2026 13.656 14.159
02-03-2026 13.869 14.379

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.